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Summary The association between body height and the incidence rate of breast cancer has been examined in
236 cases of breast cancer that occurred among 23,831 Norwegian women during 11-14 years of follow-up.
At the time of height measurement they were 35-51 years of age. The age-adjusted incidence rate ratio (IRR)
of breast cancer was 2.03 (95% of confidence limits 1.36 and 3.01) for women taller than or equal to 167 cm
(mean = 170 cm) compared to women who were less than 159 cm (mean = 155 cm). The positive association
with height was stronger among women who were diagnosed before the age of 51 (IRR = 2.63; 95%
confidence limits 1.48 and 4.68), than among women diagnosed after this age. Moreover, the association
appeared to be confined to women who had lived through their peripubertal growth during a period
(1940-45) of nationally increased nutritional variability with reduction in dietary fat and restricted caloric
intake. Among women born between 1929 and 1936, the relation with height displayed a strong positive linear
trend (X2 trend = 13.4, P< 0.001), which was not present among women born between 1925 and 1928 (X2
trend = 0.7, P = 0.40), nor among women born in 1937 or later (X2 trend = 1.5, P = 0.20). We hypothesise that
a time-dependent diversity in nourishment, which may be of particular importance for women in their
peri-menarcheal development, may explain the different association between body height and breast cancer
risk that was observed for women in different birth cohorts.
The associations between anthropometric indices and risk of
breast cancer have often been interpreted as nutritionally
dependent relations. Whereas body weight appears to be an
established risk factor for breast cancer in post-menopausal
women (Henderson et al., 1984; Boyle & Leake, 1988),
studies on the effect of height have mostly been negative
(Willett et al., 1985; Adami et al., 1977; T0rnberg et al.,
1988; Ewertz, 1988; Waaler & Lund, 1983). Some studies,
however, have found body height to be positively associated
with the risk of breast cancer (de Waard & Baanders-van
Halewijn, 1974; de Waard et al., 1977; Swanson et al., 1988).
One population-based case-control study (de Waard et al.,
1977) compared the incidence of breast cancer in a Dutch
population with that of a Japanese, and concluded that 51%
of the incidence difference could be attributed to the greater
height in the Dutch population. A relatively large prospective
study (Swanson et al., 1988) reported 90% increased risk of
breast cancer among women in the highest quintile of height
compared to those in the lowest quintile.
If an unbiased association were to exist between body
height and risk of breast cancer, it would be warranted to
pay closer attention to the peripubertal and adolescent period
in a woman's life (MacMahon, 1975; Miller, 1986), during
which her body height is determined, and her breast tissue is
being developed. Environmental conditions, such as nutri-
tional influences during childhood and adolescence (de
Waard & Trichopoulos, 1988), may be of importance for
later development of breast cancer. Biologically, understan-
ding the endocrinology of natural growth and development
during this period may provide further insight into the path-
ogenesis of breast cancer.
We have studied a cohort of women, a substantial propor-
tion of whom lived through their pubertal years during a
period of national food restriction (1940-45), which reduced
the secular height gain in the population as a whole (Brundt-
land et al., 1980). If the relation between height and breast
cancer was different among women whose menarche occurred
during this period, compared to the association with height
among women who had their pubertal growth before or after
this time, nutritional hypotheses related to a susceptible
phase of breast tissue development may be warranted for
further understanding the aetiology of breast cancer.
Methods
The study population
From 1974 to 1977 all men and women aged 35-49 years
living in three separate counties in Norway were invited to
participate in a health screening examination organised by
the National Health Screening Service. The screening proce-
dure included a questionnaire and standardised measure-
ments of height, weight, and blood pressure. A chest X-ray
was taken, and a non-fasting blood sample was drawn and
analysed on total serum cholesterol, triglycerides, and glu-
cose. The residual blood sera have since been kept frozen in a
special serum bank.
A comprehensive description of the health screening proce-
dures has previously been given by Bjartveit et al. (1979,
1983).
A total of 26,252 women were invited, among whom
24,617 (93.8%) attended the examination. Measurement of
height was missing in 499 women, and these were excluded
from analysis. A majority of the missing height
measurements were found in pregnant women. This can be
explained by the fact that height and weight measurements
were performed in conjunction with the X-ray procedure,
from which pregnant women were exempted. Moreover, all
cancer cases (including breast cancer) that had occurred
before or during the calendar year of examination were
excluded. Altogether, these counted 287 women, thus leaving
a total of 23,831 women eligible for analysis.
The questionnaire
The main objective of the primary questionnaire was to
obtain information on known and suspected risk factors for
cardiovascular disease. Consequently, there was a lack of
information on factors that are known to predict breast
cancer, such as age at menarche, age at first full term preg-
nancy, family history of breast cancer, and reliable inform-
ation on exact age at menopause. However, the questionnaire
did include detailed history of past and current smoking
habits, and various demographic variables.
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Follow-up and identification of cases of cancer
All women were followed up through the Norwegian Central
Bureau of Statistics to identify deaths in the cohort up to the
end of 1988. Being attached to each participant's record, her
official 11-digit person number enabled a linkage to the
Cancer Registry of Norway. This allowed for identification
of every incident case of breast cancer that occurred in the
cohort from the time of examination until the end of follow-
up: 1 October 1988. The reporting of malignant diseases to
the Cancer Registry is mandatory by law, and the registry
has a reliable and nearly complete registration of incident
cases of breast cancer (Lund, 1981).
A total of 236 incident cases were diagnosed in the cohort
during eleven to fourteen years of follow-up. Among these,
137 cases had occurred in women younger than 51 years, and
99 in women aged 51 or older.
The age of 51 as a dividing line for allocating breast
cancers to a pre- and post-menopausal group was arbitrarily
chosen. It can only serve as a rough separation between the
two groups, but it implies that the study includes nearly all
the premenopausal breast cancer cases that eventually will
develop in this population.
Data analysis
Body height was categorised into quartiles based on the
values found for the complete study population. For each
person belonging to a certain quartile of height, observation
years at risk of developing breast cancer were computed as
the number of years accumulated from the time of entry until
withdrawal in the year of diagnosis, at the time of death
from another cause, or at the end of follow-up, whichever
event occurred first. For breast cancer diagnosed before age
51, withdrawals were made when a person reached this age,
and observation years at risk of developing breast cancer at
age 51 or later were computed from the time a person
reached 51 years until withdrawal. This procedure allowed
comparison of overall person-time based incidence rates of
breast cancer for each quartile of height, and distinguished
risk of diagnosis made before or after the age of 51.
Incidence rate ratios (IRR) were computed as the rate in a
specific quartile of height divided by the estimated rate in the
lowest quartile. The precision of the IRR estimates was
assessed by 95% confidence limits using Miettinen's test-
based method (Kleinbaum et al., 1982; Rothman, 1986). To
explore the potential confounding or modifying effect of
cigarette smoking, the incidence rate of breast cancer as-
sociated with body height was examined separately for non-
smoking women, and for women who smoked 10 or more
cigarettes per day.
Interaction was assessed by fitting the (cumulative inci-
dence) data to a logistic model (Kleinbaum et al., 1982). The
test statistic involved comparison of maximum likelihoods
derived from different models. A model containing a product
term between body height (two categories) and the potential
modifier (cigarette smoking in two categories) was compared
to a model where the potential modifier was included only as
a co-variate.
Results
In this study there was an overall increased risk (Table I) of
breast cancer associated with increasing body height.
Women who belonged to the fourth quartile of height
(mean = 170 cm) had an age-adjusted incidence rate ratio
(IRR) of 2.03 (95% confidence limits (c.l.) 1.36 and 3.01)
compared to women in the lowest quartile (mean = 155 cm).
The risk increase associated with height displayed a linear
dose -response gradient (X2 trend = 13.50, P<0.001).
A predominant increase in risk can be attributed to women
diagnosed before the age of 51. Mean height of these cases
was 164.4 cm (95% c.l. 163.5 cm and 165.3 cm), compared to
162.5 cm in the total population. Mean height of cases diag-
nosed at age 51 or later was not different from that of the
total population.
Among cases diagnosed before the age of 51 (Table I) the
IRR for women in the tallest quartile was 2.63 (95% c.l. 1.48
and 4.68) compared to the lowest quartile. The correspon-
ding IRR among women diagnosed at age 51 or later was
1.62 (95% c.l. 0.93 and 2.81). The test for linear trend was
statistically significant among cases diagnosed before age 51
(X2 trend = 11.16, P = 0.001), whereas the effect of height
appeared to be weaker (X2 trend = 3.59, P = 0.06) among
cases who were 51 years or older at diagnosis.
Among women in this cohort the overall association with
height varied with year of birth (Table II). The positive
association between body height and breast cancer risk was
largely restricted to women who were born between 1929 and
1936 (X2 trend = 13.4, P<0.001). Among women born be-
tween 1925 and 1928 there was no overall association with
height (X2 trend = 0.7, P = 0.40), and among those born in
1937 or later there was a weak positive association (X2
trend = 1.45, P = 0.23).
We also examined whether cigarette smoking may modify
the overall association between body height and breast can-
cer risk, and found a statistically significant interaction effect
(X2 interaction = 6.14, P<0.02). The positive association
with height was stronger among women who smoked 10 or
more cigarettes per day than it was for nonsmoking women
(Table I1l). Among non-smokers the overall IRR (highest vs
lowest quartile of height) was 1.9 (95% c.l. 1.1 and 3.3),
compared to the corresponding IRR of 4.8 (95% c.l. 1.7 and
10.2) among women who daily smoked 10 or more cigarettes,
and the respective tests for trend reflected the stronger as-
sociation with height observed among regular smokers.
Discussion
In this prospective study, women who were 167 cm or taller
had a two-fold increased risk of developing breast cancer
compared to women who were shorter than 159 cm. The
increased risk associated with stature was particularly pro-
nounced among women who were diagnosed at age 50 or
younger, indicating that the effect associated with body height
may be exerted during an early period of life, and tend to be
manifested during the premenopausal years of a woman's life.
In this age group the association with height was precisely
estimated, and the gradient between height and breast cancer
risk displayed a statistically significant linear trend.
There is some support for this association in the literature
(de Waard & Baanders-van Halewijn, 1974; de Waard et al.,
1977; Swanson et al., 1988; Tretli, 1989), but most studies of
the relation between body height and breast cancer have been
negative (Boyle & Leake, 1988; Willett et al., 1985; Adami et
al., 1977; Tornberg et al., 1988; Ewertz, 1988; Waaler &
Lund, 1983).
The 23,831 participants of this study made up approx-
imately 94 percent of the eligible women living in the three
counties under study at the time of examination. A mean of
11.9 years of follow-up (range 11-14 years) constituted more
than 284,000 observed person years at risk of developing
breast cancer. The study variables were standardised meas-
urements, and information on incident breast cancer cases
was collected through the Norwegian Cancer Registry, which
reassured the completeness and reliability of the registration.
These factors would minimise any potential bias due to
selection or misclassification. In several other studies values
of body height were based on the participants' own reporting
(Willett et al., 1985; Adami et al., 1977; Ewertz, 1988), and it
cannot be excluded that the association between height and
breast cancer may suffer from non-differential mis-
classification in some of these studies, resulting in an
underestimate of the relative risk. Furthermore, failing to
distinguish between breast cancer according to age at diag-
nosis may have lead to an additional diluting effect of the
relation between height and breast cancer.
A shortcoming of this study was the lack of informationCOHORT STUDY ON HEIGHT AND BREAST CANCER 883
TableI Incidence rate ratio (IRR) ofbreastcancer according toquartiles ofbodyheight, forall cases, forcasesdiagnosed beforetheageof51 and
for cases diagnosed at age 51 or later
Body height (cm)
<159 159-162 163-166 > 167 2
Age (at measurement) mean: 155 cm 160.5 cm 164 cm 170 cm trend
All cases
35-39
Cases 8 17 20 22
Person years 18,272 22,296 23,397 26,724
40-44
Cases 10 21 19 28
Person years 21,659 23,371 23,580 21,047
45-51
Cases 19 19 32 21
Person years 28,997 27,693 24,477 20,328
Total
Cases 37 57 71 71
Person years 68,928 73,360 71,454 68,099
Age-adjusted IRR 1.0 1.46 1.91 2.03 13.50
95% confidence limits (0.96, 2.20) (1.29, 2.83) (1.36, 3.01) P<0.001
Cases<51
35-39
Cases 8 16 19 22
Person years 17,877 21,989 23,107 26,498
40 -50
Cases 6 18 26 22
Person years 24,067 25,420 24,691 21,612
Total
Cases 14 34 45 44
Person years 41,944 47,409 47,798 48,110
Age-adjusted IRR 1.0 2.11 2.72 2.63 11.16
95% confidence limits (1.15, 3.88) (1.56, 4.75) (1.48, 4.68) P = 0.001
Cases > 51
37-44
Cases 6 8 4 9
Person years 7,117 7,031 6,722 5,830
45-51
Cases 17 15 22 18
Person years 20,458 19,179 17,014 13,978
Total
Cases 23 23 26 27
Person years 27,575 26,210 23,736 19,808
Age-adjusted IRR 1.0 1.05 1.33 1.62 3.59
95% confidence limits (0.59, 1.87) (0.76, 2.31) (0.93, 2.81) P = 0.06
Dataarebasedon242incidentcasesofbreastcancerthatoccurredduring 11-14yearsoffollow-up among23,831 women aged 35-51 years in the
year of examination.
Table II Incidence rate ratio (IRR) of breast cancer, according to quartiles of body
height, for different birth cohorts of women in the study population
Birth cohort
Body height (cm) Mean 1925-28 1929-32 1933-36 1936-43
Quartiles 161.4 161.9 162.6 163.6
46 cases 65 cases 64 cases 61 cases
IRR IRR IRR IRR
< 159 155 1.0 1.0 1.0 1.0
160- 162 161 0.6 1.9 1.8 2.1
163- 166 164 1.5 2.2 2.2 2.0
> 167 170 1.1 3.1 2.5 2.1
X2 trend 0.70 8.57 4.92 1.45
P 0.40 0.003 0.03 0.23
X2 interaction' = 3.90, P = 0.05
Data are based on 236incident casesofbreastcancerthatoccurred during 11-14years
(mean= 11.9) of follow-up among 23,831 women aged 35-51 years in the year of
examination. aInteractionbetweenheight(twocategories: highestandlowestquartile)and
four birth cohorts.
on factors that are known to affect breast cancer risk. For a
factor to be confounding it should have an independent effect
on the risk of disease in the absence of the exposure under
study, and simultaneously be associated with exposure (Roth-
man, 1986). Consequently, body height should be associated
with variables such as age at menarche, age at first full term
pregnancy and family history of breast cancer for confound-
ing from these factors to be anticipated in the data.
Although the possibility of confounding from any of these
factors cannot be excluded, a brief comment on the relation
between body height and age at menarche may be justified.
There is evidence that a girl who matures early tends to be
tall for her age at onset of menarche, but the longer growth
period of a girl who has her menarche at a later age, explains
why the late maturer tends to become taller as an adult than
the early maturer (Tanner et al., 1976; Karlberg et al., 1987).884 L.J. VATTEN & S. KVINNSLAND
Table III Incidence rate ratio (IRR) of breast cancer, according to quartiles of body
height, among non-smoking women, and among women who smoked 10 or more
cigarettes per day
Body height (cm)
< 159 159-162 163-166 > 167 x2
mean 155 160.5 164 170 trend
Non-smokers
Cases 19 26 30 34
Person years 35,624 37,257 36,272 33,917
Age-adjusted IRR 1.0 1.3 1.6 1.9 5.65
95% confidence limits (0.7, 2.4) (0.9, 2.8) (1.1, 3.3) P = 0.017
Smokers ( 10 cig per
day)
Cases 5 13 18 23
Person years 16,536 18,534 18,434 18,425
Age-adjusted IRR 1.0 2.6 3.5 4.8 10.55
95% confidence limits (0.9, 7.2) (1.3, 9.3) (1.9, 12.2) P= 0.001
x2 Interactiona = 6.14, P<0.02
Dataare based on 236incidentcases ofbreastcancer that occurredduring 11- 14years
(mean= 11.9) of follow-up among 23,831 women aged 35-51 years in the year of
examination. aInteraction between height(twocategories: highestandlowestquartile)and
cigarette smoking (two categories).
An average additional height gain of seven centimeters
appears to be achieved after menarche (Rosenfield, 1989),
regardless of a girl's age at its onset. Based on abstracted
data from another, historically parallel, Norwegian cohort
(Brundtland et al., 1980; Liest0l, 1980), girls who experienced
menarche at age 14 will on average become 5 cm taller than
girls whose menarche occurred at age 12.
Early menarche is regarded as a risk factor for breast
cancer, but appears to be associated with a lower adult
height. This indicates that the positive association with height
observed in this study may be an underestimate of the effect
one would have achieved if age at menarche could have been
taken into account in the analysis.
The association between stature and breast cancer has been
attributed to a particular susceptibility that may be present
during the growth period of a woman's life (MacMahon,
1975). Nutritional factors during childhood and adolescence
may modify the relation, and interact with the endocrinology
of growth. Overnourishment, excessive intake of fat and the
total intake of calories (de Waard & Trichopoulos, 1988)
have all been suggested as potentially modifying factors that
increase future risk of breast cancer.
Among women in this cohort, the association with height
was strongly modified by year of birth. The positive associa-
tion between height and breast cancer risk was largely
confined to women who lived through their peripubertal
growth coinciding with the years of the Second World War,
which decelerated the secular height gain observed during the
prewar decades (Brundtland et al., 1980), but was compen-
sated for in the following generation within a few years after
the war was ended. Nutritional alterations, including greater
variability within the population, have been held responsible
for the changes in growth associated with this period (Gal-
tung-Hansen, 1947; Str0m, 1948). There was a marked reduc-
tion in average caloric intake chiefly due to a dramatic
reduction in animal fat, whereas protein intake was only
moderately affected. Increased height is probably not in itself
a cause of the malignancy, but it could serve the purpose of
an indicator of exposure to more directly acting causes.
Deduced from several pieces of evidence we might hypoth-
esise that nourishment during late childhood and early adol-
escence may be of particular importance for future risk of
breast cancer.
In this study we also found that the effect of height was
modified by cigarette smoking. While non-smokers experi-
enced a two-fold increase in risk associated with body height,
there was a nearly five-fold elevated risk associated with
height in women who smoked 10 or more cigarettes per day.
It seems reasonable to interpret these observations as in-
dicating that cigarette smoking interacts with the general
association between body height and breast cancer, resulting
in a further promotion of the risk.
The results of this study seem to be compatible with often
cited theoretical models of breast carcinogenesis (Moolgavkar
et al., 1980; Pike et al., 1983; Pike, 1987), and the interpreta-
tions offered also seem to have some experimental support
(Albanes & Winick, 1988). The argument is based on the
notion that an interaction of crucial significance to breast
cancer takes place between nourishment and the natural
endocrinology of growth. One nutritionally dependent conse-
quence may be differential 'turnover' rates in the mitotic
cycle of breast tissue cells during a susceptible phase of
proliferation and differentiation of the breast (Pike et al.,
1983; Key & Pike, 1988). Another possibility may be the
influence of insulin like growth factor (IGF 1), which is of
great importance in the natural somatic growth during this
period of life (Daughaday, 1989). This factor has also been
shown to be of importance for the growth of breast cancer
cells (Lippman et al., 1986).
This research is based on data made available by The National
Health Screening Service and The Cancer Registry of Norway. Dr
Vatten is a research fellow of The Norwegian Cancer Society.
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